Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis.
| Author | |
|---|---|
| Abstract | :
Vedolizumab is an effective therapy for ulcerative colitis (UC), but costly and slow to work. New clinical responses occur after 30 weeks of therapy. |
| Year of Publication | :
2018
|
| Journal | :
Alimentary pharmacology & therapeutics
|
| Date Published | :
2018
|
| ISSN Number | :
0269-2813
|
| URL | :
http://dx.doi.org/10.1111/apt.14510
|
| DOI | :
10.1111/apt.14510
|
| Short Title | :
Aliment Pharmacol Ther
|
| Download citation |